Should we use glucocorticoids in early rheumatoid arthritis? Results at 5 years from the early RA UCLouvain Brussels cohort.
OBJECTIVES: To evaluate the proportion of patients with early RA (ERA) who had or had not initiated glucocorticoids, to analyse the baseline characteristics, and to assess the clinical benefit and side effects of glucocorticoids during 5 years of follow-up. METHODS: We included patients with ERA from the UCLouvain Brussels cohort who met the ACR/EULAR 2010 classification criteria and were naïve to conventional DMARDs (cDMARDs). We retrospectively collected patient characteristics prior to the introduction of cDMARDs with or without glucocorticoids. Efficiency and serious adverse events were a... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2021 |
Verlag/Hrsg.: |
Oxford University Press
|
Schlagwörter: | Antirheumatic Agents / Arthritis / Rheumatoid / Belgium / Decision Making / Female / Follow-Up Studies / Glucocorticoids / Humans / Male / Middle Aged / Prednisolone / Registries / Retrospective Studies / Rheumatologists / Time Factors / Treatment Outcome / early arthritis / rheumatoid arthritis / treatment |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26980276 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/261597 |